Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NRG vs GSK✓SelectedUSD · GSKNRG vs GSK performance historyLatest closeAs of+2.07%11/18
Stock and ETF performance explorer

NRG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+195.4%
GSK return
+42.7%
Excess return
+152.7%
Maximum drawdown
-55.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.1%-1.3%+3.4%+2.1%
7D-3.9%-3.1%-0.8%-3.9%
30D-5.3%-0.9%-4.4%-5.2%
3M-18.5%-4.2%-14.4%-18.4%
6M-24.7%-1.6%-23.1%-24.8%
YTD-40.3%+2.6%-42.9%-40.2%
1Y-42.9%+6.2%-49.1%-42.9%
3Y+105.1%+55.0%+50.1%+97.9%
5Y+195.4%+42.8%+152.6%+178.1%
All+195.4%+42.7%+152.7%+178.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling